$63.300
-2.361 (-3.73%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
BridgeBio Pharma, Inc. (BBIO) Moving Averages Convergence Divergence (MACD) indicator is -1.99, suggesting BBIO is Strong sell.
BridgeBio Pharma, Inc. (BBIO) 20-Day simple moving average is 66.18, while BridgeBio Pharma, Inc. (BBIO) share price is $—, making it Sell.
BridgeBio Pharma, Inc. (BBIO) 60-Day simple moving average is 74.83, while BridgeBio Pharma, Inc. (BBIO) share price is $—, making it Sell.
Technical Analysis for BBIO
AI Technical BBIOAs of 2026-10-10, the technical board for BridgeBio Pharma, Inc. (BBIO) reads strong sell: 1 indicators are flashing buy, 8 are indicating sell, and 4 are neutral. Price at $64.94 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 46.778, MACD stands at -1.986 (Sell), Stochastic %K stands at 38.803, Stochastic %D stands at 28.44 and CCI stands at 44.711.
BBIO trades below the 60-day SMA (74.83) and below the 200-day SMA (73.13). Immediate resistance sits at Classic R1 68.73, then R2 71.61. Support sits at Classic S1 62.91, then S2 59.97.
BridgeBio Pharma, Inc. (BBIO) Support & Resistance Level
BridgeBio Pharma, Inc. (BBIO) Technical Indicators
2026-10-10
| Name | Value |
|---|---|
| RSI_14 | 46.778 |
| STOCHk_14_3_3 | 38.803 |
| STOCHd_14_3_3 | 28.440 |
| CCI_20 | 44.711 |
| AO_5_34 | -4.223 |
| MOM_10 | 0.280 |
| MACD_12_26_9 | -1.986 |
BridgeBio Pharma, Inc. (BBIO) Relative Strength Index (RSI_14) is 46.778, creating a Neutral signal.
BridgeBio Pharma, Inc. (BBIO) Stochastic %K is 38.803, creating a Neutral signal.
BridgeBio Pharma, Inc. (BBIO) Stochastic %D is 28.440, creating a Neutral signal.
BridgeBio Pharma, Inc. (BBIO) CCI_20 is 44.711, creating a Neutral signal.
BridgeBio Pharma, Inc. (BBIO) Awesome Oscillator (AO) is -4.223, creating a Sell signal.
BridgeBio Pharma, Inc. (BBIO) Momentum (MOM) is 0.280, creating a Buy signal.
BridgeBio Pharma, Inc. (BBIO) Moving Average Convergence Divergence (MACD) is -1.986, creating a Sell signal.
BridgeBio Pharma, Inc. (BBIO) Moving Average
2026-10-10
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 65.306 | Sell |
| MA_10 | 65.842 | Sell |
| MA_20 | 66.184 | Sell |
| MA_60 | 74.835 | Sell |
| MA_200 | 73.126 | Sell |
| MA_250 | 72.065 | Sell |
BridgeBio Pharma, Inc. (BBIO) 5-Day simple moving average is 65.306, while BridgeBio Pharma, Inc. (BBIO) share price is $, making it a Sell.
BridgeBio Pharma, Inc. (BBIO) 10-Day simple moving average is 65.842, while BridgeBio Pharma, Inc. (BBIO) share price is $, making it a Sell.
BridgeBio Pharma, Inc. (BBIO) 20-Day simple moving average is 66.184, while BridgeBio Pharma, Inc. (BBIO) share price is $, making it a Sell.
BridgeBio Pharma, Inc. (BBIO) 60-Day simple moving average is 74.835, while BridgeBio Pharma, Inc. (BBIO) share price is $, making it a Sell.
BridgeBio Pharma, Inc. (BBIO) 200-Day simple moving average is 73.126, while BridgeBio Pharma, Inc. (BBIO) share price is $, making it a Sell.
BridgeBio Pharma, Inc. (BBIO) 250-Day simple moving average is 72.065, while BridgeBio Pharma, Inc. (BBIO) share price is $, making it a Sell.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.